Families facing dementia are finding renewed hope in Brain Fitness: Processing Speed and Reaction Time, that uses ...
The King's College London study, published in Nature Communications, offers insight into how long-term inflammation may contribute to cognitive ...
Autophagy is the process by which cells remove damaged proteins, recycle worn-out organelles (e.g., mitochondria), clear ...
The Australian state of New South Wales is set to be the first jurisdiction in the world to make motor neuron disease (MND) a notifiable condition. Classifying MND in this way means that any new cases ...
Financing co-led by GordonMD Global Investments® LP and M VenturesCompany rebrands from EG 427 to Cyllene Therapeutics Paris, July 07, 2026 ...
A new study reveals experimental drug XL20 crosses the blood-brain barrier to stop toxic TDP-43 clumping in ALS.
Kenai Therapeutics, a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions, today announced the completion of enrollment for the REPLACE™ Phase 1b ...
A newly identified experimental compound, XL20, has demonstrated neuroprotective effects in mouse models and human motor ...
How does the brain prepare to hear before birth? Johns Hopkins researchers discovered an internal neural "shortcut" that ...
Across cultures, the way we soothe an unsettled baby tends to look much the same: hold them close and gently rub their back.
In a world first Australian researchers will test a one-off therapy that could repair damaged brain cells in people with ...
Latest findings on neflamapimod to be featured in presentations demonstrating its impact on dementia with Lewy bodies (DLB) disease progression, ...